164 related articles for article (PubMed ID: 30966582)
1. Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers.
Krivitsky A; Krivitsky V; Polyak D; Scomparin A; Eliyahu S; Gibori H; Yeini E; Pisarevsky E; Blau R; Satchi-Fainaro R
Polymers (Basel); 2018 May; 10(5):. PubMed ID: 30966582
[TBL] [Abstract][Full Text] [Related]
2. Systemic delivery of siRNA by aminated poly(α)glutamate for the treatment of solid tumors.
Polyak D; Krivitsky A; Scomparin A; Eliyahu S; Kalinski H; Avkin-Nachum S; Satchi-Fainaro R
J Control Release; 2017 Jul; 257():132-143. PubMed ID: 27356019
[TBL] [Abstract][Full Text] [Related]
3. Amphiphilic poly(α)glutamate polymeric micelles for systemic administration of siRNA to tumors.
Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ofek P; Tiram G; Kalinski H; Avkin-Nachum S; Feiner Gracia N; Albertazzi L; Satchi-Fainaro R
Nanomedicine; 2018 Feb; 14(2):303-315. PubMed ID: 29127036
[TBL] [Abstract][Full Text] [Related]
4. Structure-Function Correlation of Aminated Poly(α)glutamate as siRNA Nanocarriers.
Krivitsky A; Polyak D; Scomparin A; Eliyahu S; Ori A; Avkin-Nachum S; Krivitsky V; Satchi-Fainaro R
Biomacromolecules; 2016 Sep; 17(9):2787-800. PubMed ID: 27377188
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cholesterol-derived ionic copolymers as potential vectors for gene delivery.
Sevimli S; Sagnella S; Kavallaris M; Bulmus V; Davis TP
Biomacromolecules; 2013 Nov; 14(11):4135-49. PubMed ID: 24125032
[TBL] [Abstract][Full Text] [Related]
6. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
7. Structural modification of siRNA for efficient gene silencing.
Lee SJ; Son S; Yhee JY; Choi K; Kwon IC; Kim SH; Kim K
Biotechnol Adv; 2013; 31(5):491-503. PubMed ID: 22985697
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Nylon-3 Copolymer Composition on the Efficiency of siRNA Delivery to Glioblastoma Cells.
Hartl N; Adams F; Costabile G; Isert L; Döblinger M; Xiao X; Liu R; Merkel OM
Nanomaterials (Basel); 2019 Jul; 9(7):. PubMed ID: 31288448
[TBL] [Abstract][Full Text] [Related]
9. Well-Defined Cationic N-[3-(Dimethylamino)propyl]methacrylamide Hydrochloride-Based (Co)polymers for siRNA Delivery.
Singhsa P; Diaz-Dussan D; Manuspiya H; Narain R
Biomacromolecules; 2018 Jan; 19(1):209-221. PubMed ID: 29195038
[TBL] [Abstract][Full Text] [Related]
10. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing.
Lee SH; Chung BH; Park TG; Nam YS; Mok H
Acc Chem Res; 2012 Jul; 45(7):1014-25. PubMed ID: 22413937
[TBL] [Abstract][Full Text] [Related]
11. Polyplexes based on cationic polymers with strong nucleic acid binding properties.
Varkouhi AK; Mountrichas G; Schiffelers RM; Lammers T; Storm G; Pispas S; Hennink WE
Eur J Pharm Sci; 2012 Mar; 45(4):459-66. PubMed ID: 21925599
[TBL] [Abstract][Full Text] [Related]
12. Hyperbranched polymeric "star vectors" for effective DNA or siRNA delivery.
Nakayama Y
Acc Chem Res; 2012 Jul; 45(7):994-1004. PubMed ID: 22353143
[TBL] [Abstract][Full Text] [Related]
13. Dual antitumoral potency of EG5 siRNA nanoplexes armed with cytotoxic bifunctional glutamyl-methotrexate targeting ligand.
Lee DJ; Kessel E; Edinger D; He D; Klein PM; Voith von Voithenberg L; Lamb DC; Lächelt U; Lehto T; Wagner E
Biomaterials; 2016 Jan; 77():98-110. PubMed ID: 26584350
[TBL] [Abstract][Full Text] [Related]
14. Elaboration on the Distribution of Hydrophobic Segments in the Chains of Amphiphilic Cationic Polymers for Small Interfering RNA Delivery.
Wang C; Du L; Zhou J; Meng L; Cheng Q; Wang C; Wang X; Zhao D; Huang Y; Zheng S; Cao H; Zhang J; Deng L; Liang Z; Dong A
ACS Appl Mater Interfaces; 2017 Sep; 9(38):32463-32474. PubMed ID: 28862422
[TBL] [Abstract][Full Text] [Related]
15. Self-crosslinked human serum albumin nanocarriers for systemic delivery of polymerized siRNA to tumors.
Son S; Song S; Lee SJ; Min S; Kim SA; Yhee JY; Huh MS; Chan Kwon I; Jeong SY; Byun Y; Kim SH; Kim K
Biomaterials; 2013 Dec; 34(37):9475-85. PubMed ID: 24050874
[TBL] [Abstract][Full Text] [Related]
16.
Shrivats AR; Mishina Y; Averick S; Matyjaszewski K; Hollinger JO
Bioengineering (Basel); 2015 Sep; 2(3):160-175. PubMed ID: 27280121
[TBL] [Abstract][Full Text] [Related]
17. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery.
Chen G; Wang K; Wang Y; Wu P; Sun M; Oupický D
Adv Healthc Mater; 2018 Mar; 7(5):. PubMed ID: 29280311
[TBL] [Abstract][Full Text] [Related]
18. Arginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNA.
Beloor J; Choi CS; Nam HY; Park M; Kim SH; Jackson A; Lee KY; Kim SW; Kumar P; Lee SK
Biomaterials; 2012 Feb; 33(5):1640-50. PubMed ID: 22112761
[TBL] [Abstract][Full Text] [Related]
19. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
20. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
